Phase 3 AQUILA Study of Daratumumab Monotherapy Versus Active Monitoring in Patients With High-Risk Smoldering Multiple Myeloma (SMM)


Por: Dimopoulos, MA, Voorhees, P, Schjesvold, F, Cohen, YC, Hungria, V, Sandhu, I, Lindsay, J, Baker, RI, Suzuki, K, Kosugi, H, Levin, MD, Beksac, M, Stockerl-Goldstein, K, Oriol, A, Mikala, G, Garate, G, Theunissen, K, Spicka, I, Mylin, AK, Bringhen, S, Uttervall, K, Pula, B, Medvedova, E, Cowan, AJ, Moreau, P, Mateos, MV, Goldschmidt, H, Ahmadi, T, Sha, LL, Cortoos, A, Katz, EG, Rousseau, E, Li, L, Dennis, RM, Carson, R and Rajkumar, SV

Publicada: 1 sep 2025
Resumen:


Filiaciones:
Dimopoulos, MA:
 Natl & Kapodistrian Univ Athens, Alexandra Gen Hosp, Athens, Greece

Voorhees, P:
 Wake Forest Univ, Levine Canc Inst, Bowman Gray Sch Med, Atrium Hlth, Charlotte, NC USA

Schjesvold, F:
 Oslo Univ Hosp, Oslo Myeloma Ctr, Dept Hematol, Oslo, Norway

Cohen, YC:
 Tel Aviv Univ, Tel Aviv Sourasky Ichilov Med Ctr, Med Ctr, Tel Aviv, Israel

 Tel Aviv Univ, Fac Med, Tel Aviv, Israel

Hungria, V:
 Clin Med Sao Germano, Sao Paulo, Brazil

Sandhu, I:
 Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada

Lindsay, J:
 Kent & Canterbury Hosp, Kent, England

Baker, RI:
 Murdoch Univ, Perth Blood Inst, Perth, Australia

Suzuki, K:
 Japanese Red Cross Med Ctr, Tokyo, Japan

Kosugi, H:
 Ogaki Municipal Hosp, Ogaki, Japan

Levin, MD:
 Albert Schweitzer Hosp, Dordrecht, Netherlands

Beksac, M:
 Ankara Univ, Ankara, Turkiye

Stockerl-Goldstein, K:
 Washington Univ, Sch Med, St Louis, MO USA

:
 Hosp Germans Trias i Pujol, Inst Catala Oncol, Barcelona, Spain

 Hosp Germans Trias i Pujol, Inst Josep Carreras, Barcelona, Spain

Mikala, G:
 South Pest Cent Hosp, Natl Inst Hematol & Infect Dis, Budapest, Hungary

Garate, G:
 Hosp Aleman, Buenos Aires, Argentina

Theunissen, K:
 Jessa Hosp, Hasselt, Belgium

Spicka, I:
 Charles Univ Prague, Prague, Czech Republic

 Gen Hosp Prague, Prague, Czech Republic

Mylin, AK:
 Univ Copenhagen, Rigshosp, Copenhagen, Denmark

Bringhen, S:
 AOU Citta Salute & Sci Torino, SSD Clin Trials Oncoematol & Mieloma Multiplo, Turin, Italy

Uttervall, K:
 Karolinska Univ Hosp, Med Unit Hematol, Stockholm, Sweden

Pula, B:
 Inst Hematol & Transfus Med, Warsaw, Poland

Medvedova, E:
 Knight Canc Inst, Portland, OR USA

Cowan, AJ:
 Univ Washington, Seattle, WA USA

 Fred Hutchinson Canc Ctr, Seattle, WA USA

Moreau, P:
 Univ Hosp Hotel Dieu, Nantes, France

Mateos, MV:
 Univ Hosp Salamanca, Canc Res Ctr IBMCC USAL CSIC, IBSAL, Salamanca, Spain

Goldschmidt, H:
 Univ Hosp Heidelberg, GMMG Study Grp, Internal Med 5, Heidelberg, Germany

Ahmadi, T:
 Genmab US Inc, Plainsboro, NJ USA

Sha, LL:
 Johnson &Johnson, Shanghai, Peoples R China

Cortoos, A:
 Johnson & Johnson, Horsham, PA USA

Katz, EG:
 Johnson & Johnson, Raritan, NJ USA

Rousseau, E:
 Johnson & Johnson, Beerse, Belgium

Li, L:
 Johnson &Johnson, Shanghai, Peoples R China

Dennis, RM:
 Johnson & Johnson, Raritan, NJ USA

Carson, R:
 Johnson & Johnson, Spring House, PA USA

Rajkumar, SV:
 Mayo Clin, Rochester, MN USA
ISSN: 21522650





Clinical Lymphoma Myeloma & Leukemia
Editorial
Cancer Media Group, 3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA, Estados Unidos America
Tipo de documento: Meeting Abstract
Volumen: 25 Número:
Páginas:
WOS Id: 001606059100081

MÉTRICAS